A randomised control trial to investigate if people with Parkinson’s disease can exercise at high intensity, and does this improve their cardiorespiratory function? A feasibility study
Objective: To assess whether people with Parkinson’s disease (PD) are able to exercise at ≥85% of maximal heart rate during High Intensity Interval Training (HIIT)…Are the exergaming effective for improving functional exercise capacity, and quality of life in Patients with Parkinson’s Disease?
Objective: To analyze the effects of exergaming on functional exercise capacity and quality of life in patients with Parkinson's disease Background: The use of technology,…A Phase 2, Open-Label, Dose-Escalating Study to Evaluate the Safety and Preliminary Efficacy of Daxibotulinumtoxina for Injection (RT002) in Isolated Cervical Dystonia
Objective: To report preliminary 24-week outcomes of an open-label trial of daxibotulinumtoxinA for injection (RT002) for the treatment of isolated cervical dystonia (CD). (ClinicalTrials.gov ID: NCT02706795) Background:…Motor and Body Composition Variables by Parkinson’s Disease Staging
Objective: Knowing the motor variables involved in the relationship of body composition and staging of disease. Background: Functional limitation, defined as a restriction in the…Physical Mobility Predictors and the Bone Health in Parkinson’s Disease
Objective: Evaluate the physical mobility and functionality by the ratio of bone mineral density in Parkinson’s disease. Background: Bone loss in Parkinson’s disease (PD) may…Postural control is maintained after a 8-months period of exercise in people with Parkinson’s disease
Objective: Our aim was to investigate the effects of different long-lasting exercises programs on the postural control in people with Parkinson’s disease (PD). Background: Postural…WTX101 – A Novel Copper Modulating Agent for Wilson Disease Demonstrates Efficacy and Safety in a Phase 2, Multi-Center, Open Label Study
Objective: The objective of this study was to evaluate the efficacy and safety of 24 week WTX101 treatment in newly diagnosed Wilson Disease (WD) patients. Background:…A randomized, double-blind, placebo-controlled study of the D1 receptor antagonist ecopipam for children and adolescents with Tourette syndrome
Objective: To investigate the efficacy and safety of the selective dopamine D1 receptor antagonist ecopipam in children and adolescents with Tourette Syndrome (TS). Background: Dysregulation…Association of vitamin D deficiency in Parkinson disease
Objective: To identify the association between vitamin D deficiency and PD in an Arab cohort. Background: A growing body of evidence suggests that vitamin D…PROMESA: Progression Rate of MSA under EGCG Supplementation as anti-Aggregation-Approach – evaluation of serious adverse events
Objective: In the PROMESA trial (ClinicalTrials Identifier: NCT02008721) Epigallocatechingallate (EGCG) a catechine that prevents pathological protein aggregation in vitro and can be purified from green…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.